Cite

HARVARD Citation

    Lambertini, M. et al. (n.d.). New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an "ESMO Open – Cancer Horizons" Series. ESMO open. p. . [Online]. 
  
Back to record